3-(3-(4-((5-fluorofuran-2-yl)methyl)benzyl)isoxazol-5-yl)pyridin-2-amine

ID: ALA4540750

PubChem CID: 138682387

Max Phase: Preclinical

Molecular Formula: C20H16FN3O2

Molecular Weight: 349.37

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Nc1ncccc1-c1cc(Cc2ccc(Cc3ccc(F)o3)cc2)no1

Standard InChI:  InChI=1S/C20H16FN3O2/c21-19-8-7-16(25-19)11-14-5-3-13(4-6-14)10-15-12-18(26-24-15)17-2-1-9-23-20(17)22/h1-9,12H,10-11H2,(H2,22,23)

Standard InChI Key:  GZFVUJOBZSRRIV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   15.2239  -18.8325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2228  -19.6520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9308  -20.0610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.6405  -19.6516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6377  -18.8289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9290  -18.4236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3488  -20.0591    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3434  -18.4152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0912  -18.7447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.6357  -18.1353    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2244  -17.4291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4258  -17.6022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5540  -16.6813    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3663  -16.5928    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.8457  -17.2543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6574  -17.1662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9877  -16.4177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5002  -15.7566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6902  -15.8480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7999  -16.3281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2837  -16.9867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0388  -17.7654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7024  -18.2423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3610  -17.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1044  -16.9827    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.1396  -18.0070    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  2  0
  5  8  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 17 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  1  0
 24 26  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4540750

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 349.37

Molecular Weight (Monoisotopic): 349.1227

AlogP: 4.23

#Rotatable Bonds: 5

Polar Surface Area: 78.08

Molecular Species: NEUTRAL

HBA: 5

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 5.87

CX LogP: 3.45

CX LogD: 3.43

Aromatic Rings: 4

Heavy Atoms: 26

QED Weighted: 0.58

Np Likeness Score: -0.92

References

1. Trzoss M, Covel JA, Kapoor M, Moloney MK, Soltow QA, Webb PJ, Shaw KJ..  (2019)  Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp.,  29  (23): [PMID:31668974] [10.1016/j.bmcl.2019.126713]

Source

Source(1):

• Scientific Literature